(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

REZIPRES

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

REZIPRES

ST13

US500000090060774

Class

5

Filing

90060774

Registration

7043502

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

48

Latest update

04/03/2026

Classification

Registered

Trademark type

Word

Nice classes

5

Filing date

07/19/2020

Registration date

05/02/2023

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/02/2023

Last transaction

04/03/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

03/14/2022

First use in commerce

03/14/2022

Drawing code

4

Owner type

11

Owner location

Basel, CH

Examiner

MAHONEY, KATHERINE AILEEN

Law office

N90

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Dr. Reddy's Laboratories S.A.
Eton Pharmaceuticals, Inc.

Representatives

Dr. Reddy's Laboratories S.A.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for treatment of hypotension; pharmaceutical compositions for treatment of hypotension; pharmaceutical formulations for treatment of hypotension in the setting of anesthesia; pharmaceutical formulations containing ephedrine for treatment of clinically important hypotension in the setting of anesthesia; pharmaceutical formulations for treatment of hypotension

Publications

History of USPTO decisions and trademark events.

48 publications found

WOAG

WITHDRAWAL OF ATTORNEY GRANTED

06/04/2024

WOAR

TEAS WITHDRAWAL OF ATTORNEY RECEIVED

06/04/2024

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

05/02/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

05/02/2023

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

03/31/2023

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

03/30/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/15/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/15/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/15/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

09/29/2022

GNRT

NON-FINAL ACTION E-MAILED

09/29/2022

CNRT

SU - NON-FINAL ACTION - WRITTEN

09/29/2022

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

09/07/2022

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

09/03/2022

SUPC

STATEMENT OF USE PROCESSING COMPLETE

09/02/2022

EX3G

SOU EXTENSION 3 GRANTED

09/02/2022

IULN

ITU LETTER MAILED, NO RESPONSE REQUIRED

09/02/2022

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

07/13/2022

EEXT

SOU TEAS EXTENSION RECEIVED

07/12/2022

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/12/2022

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

07/12/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

07/12/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

07/12/2022

EXT3

SOU EXTENSION 3 FILED

07/11/2022

IUAF

USE AMENDMENT FILED

07/11/2022

EEXT

SOU TEAS EXTENSION RECEIVED

07/11/2022

EISU

TEAS STATEMENT OF USE RECEIVED

07/11/2022

DOCK

ASSIGNED TO EXAMINER

03/07/2022

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

01/13/2022

EX2G

SOU EXTENSION 2 GRANTED

01/11/2022

EXT2

SOU EXTENSION 2 FILED

01/11/2022

EEXT

SOU TEAS EXTENSION RECEIVED

01/11/2022

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

06/26/2021

EX1G

SOU EXTENSION 1 GRANTED

06/24/2021

EXT1

SOU EXTENSION 1 FILED

06/24/2021

EEXT

SOU TEAS EXTENSION RECEIVED

06/24/2021

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

01/12/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

11/17/2020

PUBO

PUBLISHED FOR OPPOSITION

11/17/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

10/28/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/05/2020

XAEC

EXAMINER'S AMENDMENT ENTERED

10/02/2020

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

10/02/2020

GNEA

EXAMINERS AMENDMENT E-MAILED

10/02/2020

CNEA

EXAMINERS AMENDMENT -WRITTEN

10/02/2020

DOCK

ASSIGNED TO EXAMINER

10/02/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

08/14/2020

NWAP

NEW APPLICATION ENTERED

07/22/2020

Continuous trademark protection

Get notified about every new filing that threatens REZIPRES or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.